Sleep-related hypoventilation due to a medication or substance (Q41270): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Hipoventilação relacionada ao sono devida a medicamento ou substância química é caracterizada primariamente por hipoventilação e hipercapnia crônicas devidas ao uso prolongado de medicamentos ou substâncias químicas conhecidas por deprimirem o drive respiratório e/ou comprometer a mecânica dos músculos respiratórios (p.ex. narcóticos de longa ação, anestésicos, sedativos e relaxantes musculares). Hipoxemia está usualmente também presente. Hipercapnia pode também estar presente durante a vigília em alguns pacientes. Os pacientes podem ser assintomáticos ou se queixar de dispneia, opressão torácica ou fadiga._x000D_ _x000D_ Nota: O diagnóstico definitivo requer evidência objetiva baseada em polissonografia com monitorização do dióxido de carbono (CO2) (por medidas arterial, tidal final ou transcutânea) no contexto de uso de substâncias consideradas causadoras dos sintomas. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Sleep-related hypoventilation due to a medication or substance is characterised primarily by chronic hypoventilation and hypercapnia due to prolonged use of medications or substances known to depress ventilatory drive and/or impair respiratory muscle mechanics (e.g. long-acting narcotics, anesthetics, sedative compounds, and muscle relaxants). Hypoxemia is commonly present as well. Hypercapnia may also be present during wakefulness in some patients. Patients can either be asymptomatic or present with complaints of dyspnea, chest tightness, or fatigue. Note: A definitive diagnosis requires objective evidence based on polysomnography with carbon dioxide (CO2) monitoring (by arterial, end-tidal or transcutaneous measures) in the context of medication or substance use that is judged to be causing the symptoms. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/230938285 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:7A42.4 | |||||||||||||||
| Property / CURIE: CID11:7A42.4 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-7A42.4 | |||||||||||||||
| Property / Canary Token: dki-india-7A42.4 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: G47.3 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 07:22, 13 August 2026
Sleep-related hypoventilation due to a medication or substance is characterised primarily by chronic hypoventilation and hypercapnia due to prolonged use of medications or substances known to depress ventilatory drive and/or impair respiratory muscle mechanics (e.g. long-acting narcotics, anesthetics, sedative compounds, and muscle relaxants). Hypoxemia is commonly present as well. Hypercapnia may also be present during wakefulness in some patients. Patients can either be asymptomatic or present with complaints of dyspnea, chest tightness, or fatigue. Note: A definitive diagnosis requires objective evidence based on polysomnography with carbon dioxide (CO2) monitoring (by arterial, end-tidal or transcutaneous measures) in the context of medication or substance use that is judged to be causing the symptoms.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 7A42.4 |
||
| English | Sleep-related hypoventilation due to a medication or substance |
Sleep-related hypoventilation due to a medication or substance is characterised primarily by chronic hypoventilation and hypercapnia due to prolonged use of medications or substances known to depress ventilatory drive and/or impair respiratory muscle mechanics (e.g. long-acting narcotics, anesthetics, sedative compounds, and muscle relaxants). Hypoxemia is commonly present as well. Hypercapnia may also be present during wakefulness in some patients. Patients can either be asymptomatic or present with complaints of dyspnea, chest tightness, or fatigue. Note: A definitive diagnosis requires objective evidence based on polysomnography with carbon dioxide (CO2) monitoring (by arterial, end-tidal or transcutaneous measures) in the context of medication or substance use that is judged to be causing the symptoms. |
Statements
CID11:7A42.4
0 references
dki-india-7A42.4
0 references
Concluído
0 references
13 August 2026
0 references
